However, in this study, no CV events have been reported in the medical history of patients enrolled [154]
Study findings The risk of new-onset DR was slightly higher among GLP-1 RA users (hazard ratio 1.07, a 0.2% absolute increase over two years), but the incidence of NAION was numerically higher but not statistically significant in this group
I am very grateful for Felix Fernandez-Penny, my mentor, Georg Jander, Nicole Waters Fisher, and Tiffany Fleming for giving me this opportunity and making it as enjoyable and educational as possible
I almost didn't go through with the first injection because of all the negative reviews
While leg cramps are not typically listed as a primary side effect in clinical trials, they are a frequent topic of conversation among those using GLP-1 medications